Subscribe to RSS
  • Novo Nordisk...
    PLAINSBORO, N.J., Dec. 9, 2015 /PRNewswire/ ...

    Novo Nordisk Files for Regulatory Approval of “faster-acting insulin aspart” In U.S.

    PLAINSBORO, N.J., Dec. 9, 2015 /PRNewswire/ -- Novo Nordisk announced the submission to the U.S. Food and Drug Administration of ...
  • Midatech Com...
    Midatech Pharma, the international specialty pharmaceutical ...

    Midatech Completes Acquisition of Zuplenz from Galena Biopharma

    Midatech Pharma, the international specialty pharmaceutical company focused on developing and commercialising products in oncology and other therapeutic areas, announced ...
  • Sanofi Stock...
    Given a strong drug pipeline and ...

    Sanofi Stock Update: Mergers, Licensure Agreements To Boost Company Revenue in 2016

    Given a strong drug pipeline and company financials, analysts expect Sanofi stock to do well in 2016. Sanofi ADR (NYSE:SNY) shares ...
  • Food, Drug &...
    The Food and Drug Administration (FDA) ...

    Food, Drug & Device Law Alert – FDA Issues Draft Guidance on Voluntary Labeling of GMO Foods

    The Food and Drug Administration (FDA) recently issued a draft guidance for manufacturers of human and animal food who want ...

Internationalshow all international articles

Sanofi Stock Update: Mergers, Licensure Agreements To Boost Company Revenue in 2016
Sanofi Stock Update: Mergers, Licensure Agreements To Boost Company Revenue in 2016

Given a strong drug pipeline and company financials, analysts expect Sanofi stock to do well in 2016. Sanofi ADR (NYSE:SNY) shares closed down 1.68% on December 31, 2015. The stock’s beta value is 1.00. The company has a total market capitalization of $112.90 billion, with 1.31 billion outstanding shares. In terms of sales, the drugmaker

Midatech Completes Acquisition of Zuplenz from Galena Biopharma
Midatech Completes Acquisition of Zuplenz from Galena Biopharma

Midatech Pharma, the international specialty pharmaceutical company focused on developing and commercialising products in oncology and other therapeutic areas, announced the successful completion of its previously announced acquisition of Zuplenz (ondansetron), a marketed oncology product from Galena Biopharma, Inc.

Singapore to Open Public Stem Cell Bank
Singapore to Open Public Stem Cell Bank

Singapore is all set to open a stem cell bank, which will allow members of the public to store their own stem cells for the future, officials said.

read more

Advertising & Marketingshow all advertising & marketing articles

Pfizer and Allergan Merger to Create Uncertainty for Agencies, Execs Say
Pfizer and Allergan Merger to Create Uncertainty for Agencies, Execs Say

When Pfizer announced plans to acquire Allergan for $160 billion, the first questions to surface had to do with the feasibility of the deal. What are the tax implications? What would a combined Pfizer-Allergan look like?

How to Handle Social Media Criticism
How to Handle Social Media Criticism

In today’s digital world, everyone has a voice and everyone has an opinion. While some of your social media followers may praise or thank you for the services you provide, there are always those consumers who will have something not so nice to say about you. For healthcare providers, poor reviews can be especially impactful,

FDA Wakes Up to Social Media’s Ability to Monitor Drug Adverse Events
FDA Wakes Up to Social Media’s Ability to Monitor Drug Adverse Events

Alec Gaffney reports that a recent FDA Notice of Solicitation (#1127679) calls for a “contractor capable of providing it with social media monitoring services capable of analyzing consumer sentiment and social media ‘buzz’” (read “Once Again, FDA Seeks to Leverage Social Media to Uncover Adverse Events and Public Sentiment“).”

read more

Pharma Careersshow all pharma careers articles

AAAS offers Online Science Careers Forum
AAAS offers Online Science Careers Forum

The American Association for the Advancement of Science (AAAS) provides a professional scientific forum related to employment and career development. Moderated by Dave Jensen, who has been visible in the biotech industry trade journals for more than 20 years . . . scientists can get connected, get advice and get answers. To join the forum, click here.

read more
Food, Drug & Device Law Alert – FDA Issues Draft Guidance on Voluntary Labeling of GMO Foods
Food, Drug & Device Law Alert – FDA Issues Draft Guidance on Voluntary Labeling of GMO Foods

The Food and Drug Administration (FDA) recently issued a draft guidance for manufacturers of human and animal food who want

Singapore to Open Public Stem Cell Bank
Singapore to Open Public Stem Cell Bank

Singapore is all set to open a stem cell bank, which will allow members of the public to store their

Scientists Develop a More Effective ‘Multitasking’ Flu Vaccine
Scientists Develop a More Effective ‘Multitasking’ Flu Vaccine

Researchers from Australia say they may have uncovered a way to make the seasonal flu vaccine more effective, by adding

Type 1 Diabetes App Connects Personal Records to Electronic Health Record
Type 1 Diabetes App Connects Personal Records to Electronic Health Record

In recent years, several developers have created mobile apps that allow diabetic patients to track their blood glucose readings, but

read more

Research & Developmentshow all research & development articles

FDA Releases the Pilot Version of the Clinical Outcome Assessment Compendium for Public Comment
FDA Releases the Pilot Version of the Clinical Outcome Assessment Compendium for Public Comment

The Purpose of the COA Compendium The pilot COA Compendium (view PDF) is part of FDA’s efforts to foster patient-focused

Novo Nordisk Files for Regulatory Approval of “faster-acting insulin aspart” In U.S.
Novo Nordisk Files for Regulatory Approval of “faster-acting insulin aspart” In U.S.

PLAINSBORO, N.J., Dec. 9, 2015 /PRNewswire/ — Novo Nordisk announced the submission to the U.S. Food and Drug Administration of

Scientists Develop a More Effective ‘Multitasking’ Flu Vaccine
Scientists Develop a More Effective ‘Multitasking’ Flu Vaccine

Researchers from Australia say they may have uncovered a way to make the seasonal flu vaccine more effective, by adding

read more

Regulatory Newsshow all regulatory news articles

Food, Drug & Device Law Alert – FDA Issues Draft Guidance on Voluntary Labeling of GMO Foods
Food, Drug & Device Law Alert – FDA Issues Draft Guidance on Voluntary Labeling of GMO Foods

The Food and Drug Administration (FDA) recently issued a draft guidance for manufacturers of human and animal food who want

FDA Commissioner Outlines Critical Time Ahead for Agency
FDA Commissioner Outlines Critical Time Ahead for Agency

FDA Acting Commissioner Stephen Ostroff told attendees on Tuesday at RAPS’ Regulatory Convergence that he’s seeing an “unusual confluence” of

FDA Approves First-Of-Its-Kind Product for the Treatment of Melanoma
FDA Approves First-Of-Its-Kind Product for the Treatment of Melanoma

The U.S. Food and Drug Administration today approved Imlygic (talimogene laherparepvec), the first FDA-approved oncolytic virus therapy, for the treatment

read more

Login Status

You are not currently logged in.






» Register
» Lost your Password?

Featured Whitepaper

banner
banner

FDAJob Watch

banner

Follow Us

Contacts and information

FDA RegWatch is an affiliate of MedMarket Intelligence, LLC -- a health care solutions organization. Visit us at:t: http://www.MedMarketIntel.com

Social networks

Most popular categories

Buy This Theme
© 2011 Gadgetine Wordpress theme by orange-themes.com All rights reserved.
Powered by WishList Member - Membership Software